$293 Million is the total value of ARMISTICE CAPITAL, LLC's 39 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 110.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SPDR S&P 500 ETF TRput | $19,159,000 | – | 100,000 | +100.0% | 6.54% | – | |
| GSK | New | GLAXOSMITHKLINE PLCcall | $15,380,000 | – | 400,000 | +100.0% | 5.25% | – |
| PTX | New | PERNIX THERAPEUTICS HOLDINGS | $15,168,000 | – | 4,800,000 | +100.0% | 5.18% | – |
| THRX | New | THERAVANCE BIOPHARMA INC | $14,727,000 | – | 1,341,000 | +100.0% | 5.03% | – |
| ATRS | Buy | ANTARES PHARMA INC | $14,110,000 | +6.0% | 8,300,000 | +29.7% | 4.82% | +0.8% |
| KODK | Sell | EASTMAN KODAK CO | $12,558,000 | -22.1% | 804,000 | -16.2% | 4.29% | -26.0% |
| FRPT | New | FRESHPET INC | $11,760,000 | – | 1,120,000 | +100.0% | 4.02% | – |
| XNPT | Buy | XENOPORT INC | $11,555,000 | +17.8% | 3,330,000 | +108.1% | 3.95% | +12.0% |
| ACOR | Buy | ACORDA THERAPEUTICS INC | $11,081,000 | +78.8% | 418,000 | +124.7% | 3.78% | +69.9% |
| BCOR | Buy | BLUCORA INC | $10,741,000 | -5.0% | 780,000 | +11.4% | 3.67% | -9.7% |
| BDBD | New | BOULDER BRANDS INC | $10,369,000 | – | 1,266,000 | +100.0% | 3.54% | – |
| PBY | New | PEP BOYS MANNY MOE & JACK | $10,240,000 | – | 840,000 | +100.0% | 3.50% | – |
| APOL | Sell | APOLLO ED GROUP INCcl a | $9,733,000 | -40.5% | 880,000 | -30.7% | 3.32% | -43.4% |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $8,573,000 | -40.8% | 760,000 | -33.5% | 2.93% | -43.7% |
| BDSI | Buy | BIODELIVERY SCIENCES | $8,229,000 | +158.4% | 1,480,000 | +270.0% | 2.81% | +145.6% |
| RXDX | Buy | IGNYTA INC | $8,201,000 | -37.5% | 934,000 | +7.4% | 2.80% | -40.6% |
| GMCR | New | KEURIG GREEN MTN INC | $8,030,000 | – | 154,000 | +100.0% | 2.74% | – |
| HWAY | Buy | HEALTHWAYS INC | $7,806,000 | +1.8% | 702,000 | +9.7% | 2.67% | -3.2% |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $7,787,000 | – | 506,000 | +100.0% | 2.66% | – |
| SPNC | New | SPECTRANETICS CORP | $7,357,000 | – | 624,000 | +100.0% | 2.51% | – |
| LVS | New | LAS VEGAS SANDS CORP | $7,214,000 | – | 190,000 | +100.0% | 2.46% | – |
| DECK | New | DECKERS OUTDOOR CORP | $6,967,000 | – | 120,000 | +100.0% | 2.38% | – |
| JCPNQ | Buy | J.C. PENNEY CO INC | $6,875,000 | +62.3% | 740,000 | +48.0% | 2.35% | +54.4% |
| DFRG | New | DEL FRISCOS RESTAURANT GROUP | $5,862,000 | – | 422,000 | +100.0% | 2.00% | – |
| FTDCQ | Sell | FTD COS INC | $5,543,000 | -57.1% | 186,000 | -59.4% | 1.89% | -59.2% |
| VNCE | New | VINCE HOLDING CORP | $5,282,000 | – | 1,540,000 | +100.0% | 1.80% | – |
| ANF | Sell | ABERCROMBIE & FITCH COcl a | $5,086,000 | -42.6% | 240,000 | -41.7% | 1.74% | -45.4% |
| SKUL | Sell | SKULLCANDY INC | $4,723,000 | -56.2% | 854,000 | -39.3% | 1.61% | -58.4% |
| DMD | Buy | DEMAND MEDIA INC | $4,562,000 | -25.9% | 1,094,000 | +13.0% | 1.56% | -29.5% |
| ARCO | New | ARCOS DORADOS HOLDINGS INC | $3,808,000 | – | 1,400,000 | +100.0% | 1.30% | – |
| SNTA | New | SYNTA PHARMACEUTICALS CORP | $3,480,000 | – | 2,000,000 | +100.0% | 1.19% | – |
| OSTK | Sell | OVERSTOCK COM INC DEL | $3,089,000 | -69.3% | 180,000 | -59.6% | 1.06% | -70.8% |
| MDGS | New | MEDIGUS LTDsponsored adr | $2,696,000 | – | 601,700 | +100.0% | 0.92% | – |
| CBAY | New | CYMABAY THERAPEUTICS INC | $1,622,000 | – | 836,000 | +100.0% | 0.55% | – |
| CPHRF | New | CIPHER PHARMACEUTICALS INC | $1,115,000 | – | 300,000 | +100.0% | 0.38% | – |
| NSPR | Sell | INSPIREMD INC | $1,073,000 | -41.6% | 6,500,000 | -0.9% | 0.37% | -44.5% |
| RLOC | Buy | REACHLOCAL INC | $641,000 | +0.8% | 304,000 | +50.5% | 0.22% | -3.9% |
| APHB | New | AMPLIPHI BIOSCIENCES CORP | $371,000 | – | 93,850 | +100.0% | 0.13% | – |
| TENX | New | TENAX THERAPEUTICS INC | $266,000 | – | 88,739 | +100.0% | 0.09% | – |
| FHCO | Exit | FEMALE HEALTH CO | $0 | – | -600,000 | -100.0% | -0.39% | – |
| QLTI | Exit | QLT INC | $0 | – | -660,000 | -100.0% | -0.98% | – |
| BITI | Exit | BIOTIE THERAPIES OYJsponsored adr | $0 | – | -200,000 | -100.0% | -1.44% | – |
| STKL | Exit | SUNOPTA INC | $0 | – | -424,000 | -100.0% | -1.63% | – |
| SNAK | Exit | INVENTURE FOODS INC | $0 | – | -618,000 | -100.0% | -2.25% | – |
| LPCN | Exit | LIPOCINE INC NEW | $0 | – | -850,000 | -100.0% | -2.62% | – |
| QLGC | Exit | QLOGIC CORP | $0 | – | -812,000 | -100.0% | -4.14% | – |
| TBPH | Exit | THERAVANCE BIOPHARMA INC | $0 | – | -974,000 | -100.0% | -4.56% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -4,436,000 | -100.0% | -10.90% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -150,000 | -100.0% | -11.09% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.